Friday, February 12, 2010

Bill Clinton Provides Yet Another Great Teaching Moment...

...on the health care takeov...I mean, 'reform':

Former President Bill Clinton was rushed to a Manhattan hospital late this afternoon, sources tell ABC News.
A look back at presidential history from 1960 to 2008.

Clinton, 63, was transported to Columbia Presbyterian Hospital in Manhattan for a condition related to his heart.

ABC News' chief political correspondent [and former Clintonite, ABC News forgets to disclose] George Stephanopoulos reported that sources said he was taken to the hospital "likely for a stent procedure."

He actually ended up getting two stents, and is reportedly doing well.  Now, Michelle Malkin provides the lesson:

Best wishes for the former president's recovery.

Now, a timely reminder: Stents don't grow on trees. They were not created, developed, marketed, or sold by government bureaucrats and lawmakers. One of the nation's top stent manufacturers, Boston Scientific, has weighed in on the Democrats' proposed massive taxes on medical device makers:

Boston Scientific Corp (BSX.N) warned on Tuesday that a proposed tax in the U.S. health care reform bill that cleared the Senate Finance Committee last week could have serious consequences for the company, including job losses.

"The bill that came out of the committee last week makes absolutely no sense and would be very damaging to Boston Scientific, and the medical device industry as a whole," Boston Scientific Chief Executive Ray Elliott said during a post-earnings conference call.

"In a nutshell, it would raise costs and lead to significant job losses. It does not address the quality of care but the political scorecard of savings."

Elliott said that the company's tax liability would be doubled, adding $150 million to $200 million a year, and it would be forced to make substantial cuts in research and development spending, which could result in 1,000 to 2,000 jobs being lost at Boston Scientific…

…In addition to direct fees on device makers, the industry faces a double tax because hospitals, which have agreed to accept $155 billion in cuts in government payments over 10 years, will pass on part of that burden to device makers, said Elliott.

A teachable moment: Taxing innovation in the name of "health care reform" has consequences.

I wonder how Clinton would feel about DemCare if he were required to participate in it, especially if these stents didn't already exist.

Regardless, the truth is that the taxes on innovation and the price controls that DemCare would implement are certain to have a disastrous effect on health care, and it probably won't take too many years before we start seeing it.  Throw in the fact that these companies will shed jobs and we're talking about massive pain all across America.  These stents are a perfect example of the Right's position on health care 'reform', as is the statement from the company who makes them.

Thank you, Mr. Clinton, for helping prove our case, and get better soon!

There's my two cents.

No comments: